30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 30 of 30 clinical reviews.
A clinical review of potential interactions between epitalon tetrapeptide and acetaminophen, covering CYP450 metabolism, hepatic risk, monitoring guidance, and what the published research does and does not tell us.
A pharmacology-driven analysis of potential interactions between the research peptide Epitalon and the anticoagulant apixaban (Eliquis), including CYP3A4, P-gp, and pharmacodynamic considerations.
Evidence-based analysis of the interaction between epitalon tetrapeptide and atorvastatin, covering CYP450 metabolism, pharmacodynamic overlap, monitoring parameters, and dose-adjustment considerations.
Can you take Epitalon with benzodiazepines? Learn about the pharmacodynamic overlap, CNS depression risk, melatonin-mediated sedation, and monitoring recommendations for this peptide-drug combination.
A clinical review of the potential interaction between epitalon tetrapeptide and bupropion, covering CYP2D6 inhibition, seizure threshold concerns, pharmacodynamic overlap, monitoring parameters, and dose-adjustment guidance.
Board-reviewed analysis of the epitalon tetrapeptide and clopidogrel drug interaction, covering CYP2C19 metabolism, bleeding risk, monitoring protocols, and patient counseling.
Can you take Epitalon with diphenhydramine? Review the pharmacodynamic overlap, CNS sedation risk, anticholinergic burden, and monitoring recommendations for this peptide-antihistamine combination.
Can you take Epitalon with estradiol HRT? Review the pharmacological interaction profile, shared risk pathways, monitoring protocols, and clinician guidance for combining these agents.
No published drug interaction studies exist between epitalon tetrapeptide and finasteride. Here is what the pharmacology tells us about combining them, plus monitoring recommendations from clinical principles.
Can you take Epitalon with gabapentin? A clinician-reviewed analysis of pharmacokinetic and pharmacodynamic interaction risks between epitalon tetrapeptide and gabapentin, including monitoring recommendations.
Is it safe to combine Epitalon (epithalon tetrapeptide) with hormonal birth control? A physician-reviewed look at CYP metabolism, pineal-axis effects, and monitoring recommendations.
A clinical review of the epitalon and levothyroxine interaction, covering mechanism, severity, monitoring, dose timing, and patient counseling based on available pharmacology data.
A physician-reviewed guide to the epitalon and metformin interaction, covering mechanism, pharmacokinetics, safety evidence, monitoring parameters, and patient counseling for concurrent use.
Board-reviewed analysis of the Epitalon tetrapeptide and NSAID interaction profile, covering pharmacokinetic overlap, GI and renal risk, monitoring parameters, and clinical guidance.
No direct interaction studies exist between epitalon tetrapeptide and opioids. This physician-reviewed guide covers theoretical pharmacokinetic and pharmacodynamic overlap, monitoring protocols, and safety considerations for patients using both agents.
Can you take Epitalon with PPIs like omeprazole or pantoprazole? A clinician-level review of absorption, CYP metabolism, and pH-dependent stability concerns for this peptide-PPI combination.
Can you take epitalon with prednisone? Review the pharmacodynamic overlap, immune and metabolic risks, monitoring parameters, and clinical guidance for combining epitalon tetrapeptide with glucocorticoids.
A clinical review of the epitalon-pregabalin interaction covering pharmacokinetic overlap, pharmacodynamic CNS risks, sedation monitoring, and patient counseling. Reviewed by the HealthRX medical team.
Evidence-based analysis of epitalon tetrapeptide and progesterone HRT interactions, covering CYP metabolism, sedation overlap, melatonin-progesterone crosstalk, and monitoring recommendations.
A clinician-reviewed guide to the epitalon and rivaroxaban interaction, covering mechanism, CYP3A4/P-gp pharmacokinetics, bleeding risk, monitoring, and patient counseling.
A physician-reviewed guide to the epitalon and rosuvastatin interaction, covering mechanism, severity, monitoring parameters, and patient counseling for safe concurrent use.
A clinical review of the theoretical and pharmacological interaction between epitalon tetrapeptide and sildenafil (Viagra), covering CYP metabolism, pharmacodynamics, monitoring, and patient counseling.
Can you take Epitalon with simvastatin? A clinical review of the pharmacokinetic and pharmacodynamic interaction profile between epitalon tetrapeptide and simvastatin, including CYP3A4 considerations, monitoring, and dose-adjustment guidance.
A physician-reviewed deep dive into the pharmacokinetic and pharmacodynamic interactions between epitalon tetrapeptide and SNRI antidepressants (venlafaxine, duloxetine), covering serotonin syndrome risk, CYP enzyme pathways, blood pressure monitoring, and safe co-administration guidance.
Can you take Epitalon with SSRIs like sertraline or escitalopram? Review the pharmacokinetic and pharmacodynamic interaction profile, serotonin risk, monitoring protocols, and what clinicians recommend.
A clinician-reviewed guide to the epitalon and tadalafil interaction: mechanism, safety data, hypotension risk, monitoring, and patient counseling for this research peptide plus PDE5 inhibitor combination.
A physician-reviewed deep-dive into the pharmacokinetic and pharmacodynamic interactions between epitalon tetrapeptide and testosterone therapy, covering mechanisms, monitoring, and clinical guidance.
A physician-reviewed guide to the epitalon and trazodone interaction, covering pharmacodynamic overlap, sedation risk, CYP enzyme considerations, monitoring, and practical dosing guidance.
Is it safe to take epitalon tetrapeptide with warfarin? Review of pharmacokinetic and pharmacodynamic interaction risks, INR monitoring protocols, and dose-adjustment considerations for patients on anticoagulation therapy.
Medical review of the potential interaction between epitalon tetrapeptide and zolpidem (Ambien), covering pharmacodynamic overlap, CYP3A4 metabolism, sedation risk, and monitoring recommendations.